GlassScriptPhysician profile
Muhammad Waheed
NPI 1942944913
$3,302.80
in general payments reported to CMS, 2019-2025
7 companies · $750 in 2025
The $750 reported for 2025 was more than what 85% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $303 · 2024: $2,249 · 2025: $750.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,178 · Travel and Lodging: $1,125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,177.74 |
| Travel and Lodging | $1,125.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,683.34 | 2024 | Actis |
| Stryker Corporation | $611.90 | 2023-2025 | T2 Alpha, Mako, Variax |
| Depuy Synthes Sales INC. | $576.34 | 2024-2025 | Na, N/A, Foot Osteotomy Wedge System |
| Icotec Medical INC. | $139.55 | 2025 | Kong-Tl Vbr, End Plate, Rectangular, M and Screw, 12 X 33 Mm, Kong-Tl Vbr E, Expandable Body, L, 19 Mm X 27 - 37 Mm, Vader Pedicle System 6.0, Screw, Carbon/Peek, Polyax., Fen., O 5.5 X 45 Mm |
| Cerapedics INC. | $133.85 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Si-Bone, INC. | $124.53 | 2025 | |
| Pinnacle, INC | $33.29 | 2023-2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Waheed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.